Detail akcie CV Sciences online

Business Summary: CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, CV Sciences Inc revenues decreased 1% to $16M. Net income applicable to common stockholders totaled $3.1M vs. loss of $9.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net Income reflects Hemp-Based CBD welness Products segment income totaling $3.4M vs. loss of $6.8M.